Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
New B7 Family Immune Checkpoint Proteins
Targeting immune checkpoint regulators such as programmed cell death 1 (PD-1)/PD-1 ligand 1 (PD-L1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) has achieved notable benefit in a variety of cancers. Recently five new B7 family ligands, B7-H3, B7-H4, B7-H5, B7-H6 and B7-H7, were identified, all of them possibly being of high interest in immunotherapy research.
B7-H3 [CD276] has a co-inhibitory function on T cells. Its expression on either tumor cell or diffuse tumor vasculature is significantly associated with an increased risk of death and bad outcome. Targeting B7-H3 not only enhances anti-tumor immunity but also inhibits tumor angiogenesis.
B7-H4 plays a significant role in the “immune escape” of tumors and is a potential therapeutic target for the treatment of cancer. It plays an important role in the T cell-mediated immune response as a negative regulator. The ligation of B7-H4 to unidentified receptors results in the inhibition of TCR-mediated T cell proliferation, cell-cycle progression and IL-2 production.
VISTA [V-domain immunoglobulin suppressor of T cell Activation; B7-H5] is type I Ig membrane protein homologous to PD-L1. VISTA is mainly expressed on hematopoietic tissues (spleen, thymus and bone marrow) and on myeloid cells. VISTA is a new negative checkpoint regulator that potently suppresses T cell activation. It delivers a co-inhibitory impact on T cell response. Recent publications have reported that a recombinant VISTA protein needs to be multimerized to be active as a soluble ligand. The protein VISTA (mouse):COMP (mouse) (with the extracellular domain of mouse VISTA fused to the pentamerization domain from the cartilage oligomeric matrix protein (COMP), but not VISTA-Fc, has been shown to function as an immunosuppressive agonist in vivo inhibiting the proliferation of CD4+ T cells. Additionally, a new function of the protein P-selectin glycoprotein ligand-1 (PSGL-1) as a new receptor for the immune checkpoint VISTA has been shown. Multimer VISTA binds PSGL-1 expressed on leukocytes at acidic pH, but not at the physiological pH 7. VISTA - PSGL-1 interaction shows that immune response can be regulated by acidic environments found in tumors.
B7-H6 (also known as NCR3LG1) is a ligand for NK cell activating receptor NKp30. It is expressed on tumor cells but can also be induced by inflammatory stress in healthy cells. B7-H6 has been validated as a potential target for antitumor immunotherapy strategies in tumor-bearing mice. The expression of B7-H6 is significantly correlated with post-operative prognosis in cancer patients and with distant metastasis status.
B7-H7 is widely expressed in human malignancies and its expression is associated with poor prognostic factors. Targeting B7-H7 not only benefits antitumor immunity but also inhibits tumor angiogenesis. For B7-H7, a T cell co-inhibitory role and a co-stimulatory role have been reported, most probably based on two counter receptors, one CD28H and the other unknown.
LIT: New B7 family checkpoints in human cancers: L. Ni & C. Dong; Mol. Cancer Ther. 16, 1203 (2017) • VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses: A. Prodeus, et al.; JCI Insight 2, e94308 (2017)
NEW VISTA is an acidic pH-selective Ligand for PSGL-1
PSGL-1 (human):Fc (human) (rec.) (Prod. No. AG-40B-0190) binds to its ligand VISTA only at acidic pH. Method: VISTA (human):COMP (mouse) (rec.) (His) (Prod. No. AG-40B-0183) or an unrelated protein Nampt (human) (His) (Prod. No. AG-40A-0031Y)(Control) is coated on an ELISA plate at 1μg/ml overnight at room temperature. PSGL-1 (human):Fc (human) (rec) (Prod. No. AG-40B-0190) is incubated (starting at 1000ng/ml with a twofold serial dilution) for one hour in mild acidic (pH 6.4) or neutral conditions (pH 7.4) and then detected using an anti-human Fc antibody (HRP).
Product Name | PID | Source | Endotoxin | Species |
PSGL-1 (human):Fc (human) (rec.) | AG-40B-0190 | HEK293 cells | <0.01EU/µg | Human |
NEW: B7-H3 (human) ELISA Kit - Biomarker for Immuno-Oncology Research
The B7-H3 (human) ELISA Kit (Prod. No. AG-45B-0025) is a sandwich ELISA for specific quantitative determination of soluble human B7-H3 (CD276) in serum, plasma and cell culture supernatants. Soluble human B7-H3 (CD276) is ectopically expressed in various cancers and its levels in serum of patients with cancer suggests it can be used as a noninvasive biomarker for diagnosis, prognosis and/or treatment response.
Biologically Active New B7 Family Proteins
Product Name | PID | Source | Endotoxin | Species |
B7-H3 [CD276] (mouse):Fc (mouse) (rec.) | CHI-MF-110B7H3 | CHO cells | <0.06EU/µg | Mouse |
B7-H3 [CD276] (human) (rec.) (untagged) | CHI-HF-200B7H3 | HEK 293cells | <0.01EU/µg | Human |
B7-H3 [CD276] (human):Fc (human) (rec.) | CHI-HF-210B7H3 | CHO cells | <0.06EU/µg | Human |
B7-H3 [CD276] (human):Fc (mouse) (rec.) | CHI-HF-211B7H3 | CHO cells | <0.06EU/µg | Human |
B7-H3(4Ig) [B7-H3b] (human) (rec.) (His) | CHI-HF-201B7H3B | HEK 293 cells | <0.01EU/µg | Human |
B7-H3(4Ig) [B7-H3b] (human):Fc (mouse) (rec.) | CHI-HF-211B7H3B | HEK 293 cells | <0.005EU/µg | Human |
B7-H4 (mouse):Fc (mouse) (rec.) | CHI-MF-110B7H4 | CHO cells | <0.06EU/µg | Mouse |
B7-H4 (human) (rec.) (untagged) | CHI-HF-200B7H4 | HEK 293 cells | <0.01EU/µg | Human |
B7-H4 (human) (rec.) (His) | CHI-HF-201B7H4 | HEK 293 cells | <0.01EU/µg | Human |
B7-H4 (human):Fc (human) (rec.) | CHI-HF-210B7H4 | CHO cells | <0.06EU/µg | Human |
B7-H4 (human):Fc (mouse) (rec.) | CHI-HF-211B7H4 | CHO cells | <0.06EU/µg | Human |
B7-H4 (human):Fc (rabbit) (rec.) | CHI-HF-212B7H4 | HEK 293 cells | <0.005EU/µg | Human |
NEW VISTA (mouse):COMP (mouse) (rec.) (His) | AG-40B-0181 | HEK 293 cells | <0.01EU/µg | Mouse |
VISTA [B7-H5] (mouse):Fc (human) (rec.) | AG-40B-0164 | HEK 293 cells | <0.01EU/µg | Mouse |
NEW VISTA (human):COMP (mouse) (rec.) (His) | AG-40B-0183 | HEK 293 cells | <0.01EU/µg | Human |
VISTA [B7-H5] (human) (rec.) (His) | AG-40B-0177 | HEK 293 cells | <0.01EU/µg | Human |
VISTA [B7-H5] (human) (rec.) (His) | CHI-HF-201B7H5 | HEK 293 cells | <0.06EU/µg | Human |
VISTA [B7-H5] (human):Fc (human) (rec.) | AG-40B-0163 | HEK 293 cells | <0.01EU/µg | Human, Mouse |
VISTA [B7-H5] (human):Fc (mouse) (rec.) | CHI-HF-211B7H5 | HEK 293 cells | <0.005EU/µg | Human |
B7-H6 (human):Fc (mouse) (rec.) | CHI-HF-211B7H6 | HEK 293 cells | <0.005EU/µg | Human |